Navigation Links


Enhanced in Medical Technology

Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer

... ("CR") rate when given OPAXIO, a biologically enhanced paclitaxel, in addition to cisplatin and ... data suggest paclitaxel poliglumex may provide enhanced radiation sensitization as compared to standard ... be influenced by estrogen, which could lead to enhanced release of paclitaxel and efficacy in women with ...

Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay

... of the patient population by use of the enhanced version of Monogram's Trofile(TM) Assay. The ... the trial. In June 2008 Monogram introduced an enhanced sensitivity version of the Trofile Assay, with ... original samples from the MERIT trial using the enhanced Trofile assay. These samples had been previously ...

Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City

... MDX-1401 is a second-generation antibody enhanced for improved antibody effector function over the ... -- MDX-1342 is a fully human antibody with enhanced antibody effector function that selectively binds ... -- MDX-1411 is a fully human antibody with enhanced antibody effector function that targets CD70, a ...

Spectrum Pharmaceuticals Announces Presentation of SPI-1620 Data at the AACR-NCI-EORTC International Conference

... tumor blood perfusion, and significantly enhanced the uptake and delivery of paclitaxel to the ... in drug delivery to tumors, which in turn enhanced the efficacy of the chemotherapeutic drugs. ... shown in animal models. Furthermore, SPI-1620 enhanced the efficacy of chemotherapeutic drugs ...

Medarex Announces Preclinical Data from Multiple Research Programs Demonstrating Anti-Tumor Activity in Cancer

... MDX-1110 also demonstrated potent anti-tumor activity as a monotherapy and enhanced efficacy and improved control of tumor cell growth in combination with ... model with no evidence of toxicity. Targeting glypican-3 with antibodies enhanced for antibody-dependent cell-mediated cytotoxicity properties, as ...

Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer

... conducted in healthy volunteers demonstrated that SPI-452 substantially enhanced the exposures of three currently approved HIV protease inhibitors (PIs). ... single-dose in vivo animal studies. SPI-452 consistently and significantly enhanced the systemic exposure of the co-administered HIV PIs comparable with ...

Medarex Announces Enhanced Activity Data with Second Generation Anti-CD30 Antibody for Malignant Lymphoma

... potency and efficacy of MDX-1401 in in vivo xenograft models indicates enhanced antibody-dependent cellular cytotoxicity (ADCC) activity, an important ... are excited with the growing body of scientific evidence that indicates enhanced ADCC and improved anti-tumor efficacy with the second generation anti-CD30 ...

Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution

... International Corporation (Nasdaq: PRXL ), announced today that it has enhanced its TrialWorks(R) solution, a specialized Clinical Trial Management System (CTMS) designed specifically for small and mid-size companies. The enhanced 2.1 version of the TrialWorks solution has updated functionality for ...

Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models

... treatment with chemotherapy and pegylated enzyme produces significantly enhanced survival compared to chemotherapy alone - - Pegylated ... activity. The docetaxel combination treatment demonstrated significantly enhanced survival compared to treatment with the chemotherapeutic agent alone. The ...

Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format

... Interleukin Genetics, Inc. (Amex: ILI ), today announced the launch of an enhanced test report format and information package for the company's Heart Health ... studies and conducted by the company. The company believes that this enhanced report format will provide individuals and their physicians more complete ...

Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City

... by PCT may result in new therapeutic strategies, diagnostic paradigms, and enhanced analysis of samples. About Pressure BioSciences, Inc. Pressure ... PCT may result in new therapeutic strategies, diagnostic paradigms, and enhanced analysis of samples. These statements are based upon the Company's ...

Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting

... Annual Meeting 2008 in San Diego, California, the data also featured the enhanced pharmacokinetic profile and tolerability of NKTR-102, as compared to ... tumors" #5741: "NKTR-102, a novel PEGylated-irinotecan, has an enhanced pharmacokinetic profile with reduced gastrointestinal and hematopoietic ...

Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing

... Include Increased Productivity and End-User Satisfaction, enhanced Workflow and Quality of Care Improvements ORLANDO, Fla., Feb. 25 ... can use computing technology in new ways and places. The company's enhanced line of tablet PCs, mobile clinical assistants and accessories are ...

Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics

... FOBs market would provide to patients and healthcare providers; -- An enhanced Insmed website containing enhanced FOB resources and updates; -- Interactive advocacy program utilizing ...

Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio

... the mechanical properties of tissue providing additional information for enhanced diagnostic decision-making. Clinical studies indicate that elasticity ... as a biomarker, syngo GRACE provides improved differential diagnosis and enhanced confidence in therapy monitoring. Advances in Immunodiagnostics New ...

MedicAlert Foundation Joins The Alzheimer's Association to Offer MedicAlert(R) + Alzheimer's Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies

... ) MedicAlert + Safe Return will provide enhanced services including assistance when a person wanders or is lost and access ... and family contacts, insurance information, and advance directives. "Our enhanced service offerings in collaboration with the Alzheimer's Association will ...

Rx for Africa, Inc. Now Trading Under New Symbol (RXAF.PK)

... including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's partners or ...

New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production

... seems to allow people to move faster when exercising by satisfying the enhanced muscle oxygen demand and increasing the blood flow to active muscles. When ... supplying muscles, which makes them expand, a process that requires enhanced production of NO." A multitude of studies about Pycnogenol(R) and sports ...

Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer

... toxicity (see SPC). Sequential radiotherapy (given >7 days apart): enhanced toxicity has not occurred when gemcitabine was started after the resolution of acute radiation effects or at least one week after radiation. enhanced toxicity from radiation therapy following gemcitabine exposure has not ...

OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer

... chemotherapy. Preclinical and clinical studies support that OPAXIO metabolism by lung cancer cells may be influenced by estrogen, which could lead to enhanced release of paclitaxel and efficacy in women with lung cancer compared to standard therapies. About Cell Therapeutics, Inc. Headquartered ...

VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE

... of the heart to identify and quantify biomarkers of monocyte activity in vivo . These results enabled an important data correlation that further enhanced the integrated array of in vitro assays and microscopy-based readouts of this important pathway." About VisEn Medical Inc. ...

National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness

... Unlike other chemotherapy agents, including trabectedin, the NCI research indicates that the tumor cell DNA damaging effects of brostallicin are enhanced by high tumor glutathione levels, a hallmark of drug-resistant tumors. Brostallicin was shown to affect DNA in both dividing and quiescent cells. ...

Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study

... risks and uncertainties include, but are not limited to, our compliance with the Corporate Integrity Agreement through 2012; the impact of our enhanced healthcare compliance global initiatives and business practices on our relationships with customers and consultants, our market share and our overall ...

New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%

... clinical research demonstrating strong health benefits. Plain inulin is a far cheaper prebiotic which is used in most prebiotic supplements and enhanced foods. "The implications of this study are somewhat staggering," says Jackson GI Chairman and Founder Frank W. Jackson, M.D. "While the research ...

Brain Fitness Makes Boomers Age Younger

... a journal for doctors who are board certified in Geriatrics. It confirms earlier studies showing similar effects and imaging research showing enhanced brain activity. Posit Science Posit Science is the leading provider of scientifically proven brain fitness programs. The company works with ...

CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders

... in the peripheral neuropathies associated with diabetes, kidney disease, cancer chemotherapy and other conditions. In preclinical studies, CXB909 enhanced the action of NGF in vitro , amplifying its activity almost seven-fold. CXB909 was neuroprotective in a variety of cellular assays and in animal ...

Published Study Shows VNUS ClosureFAST(TM) System Significantly Superior to Laser for Varicose Vein Treatment

... "The study confirms what many of us who have used both laser and radiofrequency devices have felt subjectively - that there is significantly enhanced patient comfort with the radiofrequency technology," said Raymond G. Makhoul, M.D., of Richmond, Virginia, a researcher for the study. "The ...

ThermoGenesis Announces National Institute of Health Grant

... Company's research is based upon the growing body of evidence which shows that the efficacy of stem cells for tissue regeneration and repair can be enhanced if the cells are presented to the body within bioengineered materials. The AXP is used for the processing of stem cells from umbilical cord ...

Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association

... assessing more than 10 dosing regimens, have led to the identification of a dosing regimen that is expected to result in optimal TCR modulation, enhanced tolerability, no immunogenicity, beneficial clinical activity, and an improved safety profile. This regimen is currently being evaluated in the ...

Pixantrone in Combination with Chemotherapy Regimens Produces Overall Response Rates of 58-74% with Complete Remission Rates of 37-57% in Relapsed/Refractory Aggressive or Indolent NHL

... in hematologic cancers over standard anthracyclines and the rational design modifications to the chemical compound believed to be responsible for enhanced DNA damage and binding to topoisomerase II enzyme, a key target for anthracycline mediated tumor death. These modifications are also hypothesized by ...

Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease

... for treating iliac disease." The EPIC Stent is a self-expanding nitinol stent designed to sustain vessel patency (openness), while providing enhanced visibility during placement. The ORION trial incorporates stent diameter ranges from 6-12 mm and lengths up to 120 mm. All stent sizes are ...

Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent

... and a lower profile, designed to improve radial strength, recoil and angiographic visibility. Deliverability to complex lesions is further enhanced through the incorporation of a new highly deliverable dilatation catheter technology. "It is particularly important to have a range of options ...

Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results

... which results in constriction and increasing blood pressure. In addition, angiotensin II stimulates the release of another hormone that causes enhanced sodium and chloride (salt) retention, with a resultant increase in vascular water retention and blood volume that also contributes to an elevation in ...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

... which results in constriction and increasing blood pressure. In addition, angiotensin II stimulates the release of another hormone that causes enhanced sodium and chloride (salt) retention, with a resultant increase in vascular water retention and blood volume that also contributes to an elevation in ...

InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients

... delivered and the patient was released from the hospital after a few days with no complications. Dr. Horak stated: "I feel MGuard(TM) offers enhanced safety during the procedure by preventing defragmentation of the thrombus. I look forward to seeing good clinical results for both the one-month and ...

Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies

... and the tumor microenvironment, showing that the anti-PS antibody induced a sequential release of cytokines and beta-chemokines and stimulated enhanced macrophage recruitment to tumors. Furthermore, the researchers showed that in vitro, PGN635 induced antibody-dependent death of endothelial cells, ...

Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes

... more convenient treatment option." About Intarcia Intarcia Therapeutics, Inc. is a biopharmaceutical company developing therapies to ensure enhanced treatment outcome by optimizing patient adherence and improving the convenience and tolerability of drug therapies. Intarcia's drug development ...

Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia

... for a new use," Dr. Ge said. "It looks like the increased drug activity or synergy is not due to the transport or delivery of clofarabine, but to enhanced cell death. We were so pleased with the results." AML afflicts mostly adults -- about 10,000 new cases each year -- and strikes older children. ...

Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies

... and the tumor microenvironment, showing that the anti-PS antibody induced a sequential release of cytokines and beta-chemokines and stimulated enhanced macrophage recruitment to tumors. Furthermore, the researchers showed that in vitro , PGN635 induced antibody-dependent death of endothelial cells, ...

Pivotal Clinical Data Published for the Only Laser Phototherapy Device Cleared by the FDA for Hair Growth

... has the building blocks and energy to transform from a weakened follicle to one that is healthy and capable of producing thick terminal hair. The enhanced environment in turn invigorates the hair follicle which produces healthier hair, prevents further hair loss and stimulates the re-growth of thicker ...
Other Contentsosteomyelitisosteosarcomaexternaosteoporosisosteoporosisosteoporosisosteoporosisosteoporosisosteoporosisostomyosteopathymediamediamediamediamediamediamediamediamedia
(Date:12/14/2009)... by sneezing, touching, or for Tasmanian devils ... may have driven the dinosaurs to extinction through the ... member of f1000 Biology, highlights the ,paleobiological detective work, ... This led them to deduce that a protozoan parasite ... in many tyrannosaurid fossils. , The parasite,s modern-day equivalent, ...
(Date:12/14/2009)... spending the holidays with big Uncle Frank or bossy ... off with another family, spare a thought for the ... McMaster University and the University of New South Wales ... in groups, members make strategic decisions about their living ... issue of Biology Letters . , The helper ...
(Date:12/14/2009)... United Nations Framework Convention on Climate Change taking ... the ,Bend the Trend, event on Sunday evening ... premiere the screening of the new ,Environmental Atlas ... a joint project of the European Environment Agency ... is a series of short films showing the ...
Breaking Biology News(10 mins):'Environmental Atlas of Europe' unveiled at COP15 2Brain Protein Tied to Retardation 59897 1iLife Americas LLC Enters U S Wellness and Therapeutic Markets 14561 1iLife Americas LLC Enters U S Wellness and Therapeutic Markets 14561 2DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America 59892 1DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America 59892 2DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America 59892 3
(Date:12/15/2009)... caring, conscientious practice you have ever been a part of. We ... we can help to achieve this goal and meet your expectations." ... ... The Dermatology Center of Dallas, a Dallas based, full-service medical and ... Foshee, MD in their practice. Dr. Foshee joins James H. ...
(Date:12/15/2009)... 1, 2010 Oregon will require that certain businesses with large ... external defibrillator (AED) readily available. Fire and rescue personnel agree ... is a good investment. , ... ... 2010 Oregon will require that certain businesses with large areas ...
(Date:12/15/2009)... San Diego Hospice and The Institute for Palliative Medicine ... 14, 2009. Mr. Price has been known for his ... business, community and personal life. Mr. Price was a ... of philanthropy and the role it plays in the ... countless philanthropic efforts. We extend our condolences to the ...
(Date:12/15/2009)... UT Southwestern Medical Center researchers have provided the ... observable characteristics seen in patients with an extremely ... online and in the December issue of the ... suggest that patients with atypical progeroid syndrome (APS) ... with two similar but more well-defined accelerated aging ...
(Date:12/14/2009)... more… , ... Santa Barbara, California ... scientists at University of Michigan, have developed synthetic particles that ... blood cells, including softness, flexibility, and the ability to carry ... natural red blood cells is to carry oxygen, and the ...
Breaking Medicine News(10 mins):Health News:Jeri Beth “J.B.” Foshee, MD Joins Dermatology Center of Dallas 2Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 2Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 3Health News:San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price 2Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3
Other TagsactorsactorsactorsmeanmeanOther Tagsviable 2viable 3viable 4viable 5viable 6viable 7opinions 2opinions 3conflicting 2conflicting 3third 2third 3third 4third 5third 6third 7third 8third 9third 10one 2one 3one 4one 5one 6one 7one 8one 9one 10finds 2finds 3finds 4finds 5team 2team 3team 4team 5team 6team 7team 8team 9team 10